Corient Capital Partners’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.27M Buy
23,539
+11
+0% +$641 0.1% 175
2022
Q2
$1.27M Buy
23,528
+782
+3% +$45.4K 0.1% 183
2022
Q1
$1.31M Sell
22,746
-175
-0.8% -$8.95K 0.09% 204
2021
Q4
$1.08M Sell
22,921
-7,981
-26% -$363K 0.07% 218
2021
Q3
$1.3M Buy
30,902
+1,277
+4% +$55.2K 0.1% 197
2021
Q2
$1.31M Buy
29,625
+1,462
+5% +$67.5K 0.1% 188
2021
Q1
$1.31M Buy
28,163
+2,290
+9% +$101K 0.11% 162
2020
Q4
$1M Buy
25,873
+45
+0.2% +$1.61K 0.1% 180
2020
Q3
$744K Sell
25,828
-1,861
-7% -$52.4K 0.09% 199
2020
Q2
$741K Sell
27,689
-1,360
-5% -$35.4K 0.09% 201
2020
Q1
$683K Buy
29,049
+21,279
+274% +$585K 0.11% 164
2019
Q4
$230K Buy
+7,770
New +$206K 0.03% 410

Other funds holding CTVA

Corient Capital Partners's CTVA Position: Q3 2022 in Review

Corient Capital Partners increased its Corteva (CTVA) stake by 0.05% in Q3 2022, buying an estimated $641 and bringing the position to 23,539 shares worth $1.27M. The position accounts for 0.1% of the portfolio, ranked #175.

Corient Capital Partners first reported a position in CTVA in Q4 2019 and has held it in 12 quarters since. The position peaked at $1.31M in Q2 2021. 1,225 funds tracked by Wall St. Rank hold CTVA as of Q3 2022.

  • Corient Capital Partners held 23,539 shares of Corteva worth $1.27M as of Q3 2022.
  • Corient Capital Partners bought 11 Corteva shares in Q3 2022, an estimated $641.
  • Corteva made up 0.1% of Corient Capital Partners's portfolio in Q3 2022, its #175 holding.
  • Corient Capital Partners first reported a position in Corteva in Q4 2019 and has held it in 12 quarters since.
  • Corient Capital Partners's Corteva position peaked at $1.31M in Q2 2021.
  • 1,225 funds tracked by Wall St. Rank held Corteva as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.